Primary hyperaldosteronism other imaging findings: Difference between revisions
Created page with "__NOTOC__ {{Conn syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{reflist|2}}..." |
No edit summary |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Primary hyperaldosteronism}} | ||
{{CMG}};{{AE}}{{HK}} | |||
==Overview== | |||
[[Scintigraphy|Iodocholesterol scintigraphy]] (NP-59 scan) may be helpful in the diagnosis of primary aldosteronism. Findings on an [[Scintigraphy|Iodocholesterol scintigraphy]] (NP-59 scan) suggestive of primary aldosteronism is increased uptake of the [[Adrenal gland|adrenal glands]]. | |||
==Other Imaging Findings== | |||
=== '''Iodocholesterol scintigraphy (NP-59 scan)''' === | |||
*6 beta- 131I iodomethyl-19-norcholesterol (NP-59), was introduced in 1977 for the diagnosis for primary aldosteronism. | |||
*The NP-59 scan is performed with [[Dexamethasone suppression test|dexamethasone suppression]]. | |||
*It is not very useful in identifying micro [[adenomas]] of the [[Adrenal gland|adrenals]] (<1.5 cm).<ref name="pmid24235884">{{cite journal |vauthors=Chen YC, Chiu JS, Wang YF |title=NP-59 SPECT/CT imaging in stage 1 hypertensive and atypical primary aldosteronism: a 5-year retrospective analysis of clinicolaboratory and imaging features |journal=ScientificWorldJournal |volume=2013 |issue= |pages=317934 |year=2013 |pmid=24235884 |pmc=3818974 |doi=10.1155/2013/317934 |url=}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 18:19, 3 November 2017
|
Primary hyperaldosteronism Microchapters |
|
Differentiating Primary Hyperaldosteronism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary hyperaldosteronism other imaging findings On the Web |
|
American Roentgen Ray Society Images of Primary hyperaldosteronism other imaging findings |
|
Primary hyperaldosteronism other imaging findings in the news |
|
Risk calculators and risk factors for Primary hyperaldosteronism other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Iodocholesterol scintigraphy (NP-59 scan) may be helpful in the diagnosis of primary aldosteronism. Findings on an Iodocholesterol scintigraphy (NP-59 scan) suggestive of primary aldosteronism is increased uptake of the adrenal glands.
Other Imaging Findings
Iodocholesterol scintigraphy (NP-59 scan)
- 6 beta- 131I iodomethyl-19-norcholesterol (NP-59), was introduced in 1977 for the diagnosis for primary aldosteronism.
- The NP-59 scan is performed with dexamethasone suppression.
- It is not very useful in identifying micro adenomas of the adrenals (<1.5 cm).[1]
References
- ↑ Chen YC, Chiu JS, Wang YF (2013). "NP-59 SPECT/CT imaging in stage 1 hypertensive and atypical primary aldosteronism: a 5-year retrospective analysis of clinicolaboratory and imaging features". ScientificWorldJournal. 2013: 317934. doi:10.1155/2013/317934. PMC 3818974. PMID 24235884.